Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$669K Sell
12,445
-15,893
-56% -$881K 0.49% 27
2017
Q3
$1.73M Sell
28,338
-18,434
-39% -$1.12M 1.19% 36
2017
Q2
$2.86M Sell
46,772
-262
-0.6% -$15.9K 1.85% 22
2017
Q1
$2.85M Hold
47,034
1.87% 22
2016
Q4
$2.64M Buy
+47,034
New +$2.75M 1.88% 21

Other funds holding MRK

Blue Granite Capital's MRK Position: Q4 2017 in Review

Blue Granite Capital reduced its Merck (MRK) stake by 56% in Q4 2017, selling an estimated $881K and leaving 12,445 shares worth $669K. The position accounts for 0.49% of the portfolio, ranked #27.

Blue Granite Capital first reported a position in MRK in Q4 2016 and has held it in 5 quarters since. The position peaked at $2.86M in Q2 2017. 2,008 funds tracked by Wall St. Rank hold MRK as of Q4 2017.

  • Blue Granite Capital held 12,445 shares of Merck worth $669K as of Q4 2017.
  • Blue Granite Capital sold 15,893 Merck shares in Q4 2017, an estimated $881K.
  • Merck made up 0.49% of Blue Granite Capital's portfolio in Q4 2017, its #27 holding.
  • Blue Granite Capital first reported a position in Merck in Q4 2016 and has held it in 5 quarters since.
  • Blue Granite Capital's Merck position peaked at $2.86M in Q2 2017.
  • 2,008 funds tracked by Wall St. Rank held Merck as of Q4 2017.

Based on Blue Granite Capital's 13F filing for Q4 2017, filed 14 Feb 2018.